JP2005506368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506368A5 JP2005506368A5 JP2003537628A JP2003537628A JP2005506368A5 JP 2005506368 A5 JP2005506368 A5 JP 2005506368A5 JP 2003537628 A JP2003537628 A JP 2003537628A JP 2003537628 A JP2003537628 A JP 2003537628A JP 2005506368 A5 JP2005506368 A5 JP 2005506368A5
- Authority
- JP
- Japan
- Prior art keywords
- ethylamine
- methoxy
- dimethyl
- compound
- indol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 4
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- 230000037406 food intake Effects 0.000 claims description 2
- 235000012631 food intake Nutrition 0.000 claims description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 19
- 150000001875 compounds Chemical class 0.000 claims 18
- -1 4-methylpiperazinyl Chemical group 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 150000002431 hydrogen Chemical class 0.000 claims 11
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 4
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 4
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 4
- 150000002825 nitriles Chemical class 0.000 claims 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004750 (C1-C6) alkylaminosulfonyl group Chemical group 0.000 claims 2
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 2
- AIJIQCBYMBZLJD-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)-5-methoxyindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CC=C1 AIJIQCBYMBZLJD-UHFFFAOYSA-N 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- QGHQLNRTTLQPIO-UHFFFAOYSA-N 1-(benzenesulfonyl)-5-methoxy-3-(2-piperidin-1-ylethyl)indole Chemical compound C12=CC(OC)=CC=C2N(S(=O)(=O)C=2C=CC=CC=2)C=C1CCN1CCCCC1 QGHQLNRTTLQPIO-UHFFFAOYSA-N 0.000 claims 1
- KLDDKHIDNOHJGC-UHFFFAOYSA-N 1-(benzenesulfonyl)-5-methoxy-3-(2-pyrrolidin-1-ylethyl)indole Chemical compound C12=CC(OC)=CC=C2N(S(=O)(=O)C=2C=CC=CC=2)C=C1CCN1CCCC1 KLDDKHIDNOHJGC-UHFFFAOYSA-N 0.000 claims 1
- CNSLAKZIKMZGCO-UHFFFAOYSA-N 2-(5-methoxy-1-methylsulfonylindol-3-yl)-n,n-dimethylethanamine Chemical compound COC1=CC=C2N(S(C)(=O)=O)C=C(CCN(C)C)C2=C1 CNSLAKZIKMZGCO-UHFFFAOYSA-N 0.000 claims 1
- IPAXTAWQPQEGJN-UHFFFAOYSA-N 2-(5-methoxy-1-thiophen-2-ylsulfonylindol-3-yl)-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CS1 IPAXTAWQPQEGJN-UHFFFAOYSA-N 0.000 claims 1
- CJTNSRUSBFDSOH-UHFFFAOYSA-N 2-[1-(2-chlorophenyl)sulfonyl-5-methoxyindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CC=C1Cl CJTNSRUSBFDSOH-UHFFFAOYSA-N 0.000 claims 1
- HMVDWYPJGVKJPZ-UHFFFAOYSA-N 2-[1-(3-chlorophenyl)sulfonyl-5-methoxyindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CC(Cl)=C1 HMVDWYPJGVKJPZ-UHFFFAOYSA-N 0.000 claims 1
- CGLZSUIRHPCPLB-UHFFFAOYSA-N 2-[1-(4-chlorophenyl)sulfonyl-5-methoxyindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=C(Cl)C=C1 CGLZSUIRHPCPLB-UHFFFAOYSA-N 0.000 claims 1
- DNOJEKLHKJAPCC-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)-5-methoxy-2-methylindol-3-yl]-n,n-dimethylethanamine Chemical compound CC1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CC=C1 DNOJEKLHKJAPCC-UHFFFAOYSA-N 0.000 claims 1
- KJOAWSBQNSIGLK-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)-5-methoxyindol-3-yl]ethanamine Chemical compound C1=C(CCN)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=CC=C1 KJOAWSBQNSIGLK-UHFFFAOYSA-N 0.000 claims 1
- NKLZWGMWROXIDH-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)indol-3-yl]-n,n-dimethylethanamine Chemical compound C12=CC=CC=C2C(CCN(C)C)=CN1S(=O)(=O)C1=CC=CC=C1 NKLZWGMWROXIDH-UHFFFAOYSA-N 0.000 claims 1
- GIHFRARKMBMXPG-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)indol-4-yl]-n,n-dimethylethanamine Chemical compound C1=CC=2C(CCN(C)C)=CC=CC=2N1S(=O)(=O)C1=CC=CC=C1 GIHFRARKMBMXPG-UHFFFAOYSA-N 0.000 claims 1
- VNWSJGQXBGKBED-UHFFFAOYSA-N 2-[1-(benzenesulfonyl)indol-4-yl]ethanamine Chemical compound C1=CC=2C(CCN)=CC=CC=2N1S(=O)(=O)C1=CC=CC=C1 VNWSJGQXBGKBED-UHFFFAOYSA-N 0.000 claims 1
- OJPTTYMYFMZMRB-UHFFFAOYSA-N 2-[5-methoxy-1-(4-methoxyphenyl)sulfonylindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1C2=CC=C(OC)C=C2C(CCN(C)C)=C1 OJPTTYMYFMZMRB-UHFFFAOYSA-N 0.000 claims 1
- NYUGRZAAEIFCKO-UHFFFAOYSA-N 2-[5-methoxy-1-(4-methylphenyl)sulfonylindol-3-yl]-n,n-dimethylethanamine Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1S(=O)(=O)C1=CC=C(C)C=C1 NYUGRZAAEIFCKO-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- DCCVQPUCAMNNAF-UHFFFAOYSA-N 3-[1-(benzenesulfonyl)indol-4-yl]-n,n-dimethylpropan-1-amine Chemical compound C1=CC=2C(CCCN(C)C)=CC=CC=2N1S(=O)(=O)C1=CC=CC=C1 DCCVQPUCAMNNAF-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- LMIQERWZRIFWNZ-UHFFFAOYSA-N 5-hydroxyindole Chemical compound OC1=CC=C2NC=CC2=C1 LMIQERWZRIFWNZ-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- JQCCQHBMYRBHBD-UHFFFAOYSA-N [3-[2-(dimethylamino)ethyl]-5-methoxyindol-1-yl]-phenylmethanone Chemical compound C1=C(CCN(C)C)C2=CC(OC)=CC=C2N1C(=O)C1=CC=CC=C1 JQCCQHBMYRBHBD-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 230000036528 appetite Effects 0.000 claims 1
- 235000019789 appetite Nutrition 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 claims 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- VXKXFPCXSPRMGE-UHFFFAOYSA-N n,n-dimethyl-2-(1-methylsulfonylindol-3-yl)ethanamine Chemical compound C1=CC=C2C(CCN(C)C)=CN(S(C)(=O)=O)C2=C1 VXKXFPCXSPRMGE-UHFFFAOYSA-N 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- XNGOFLDLWLHOJS-UHFFFAOYSA-N tert-butyl 3-[2-(dimethylamino)ethyl]-5-hydroxyindole-1-carboxylate Chemical compound C1=C(O)C=C2C(CCN(C)C)=CN(C(=O)OC(C)(C)C)C2=C1 XNGOFLDLWLHOJS-UHFFFAOYSA-N 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103539A SE0103539D0 (sv) | 2001-10-23 | 2001-10-23 | New Use |
| US34059901P | 2001-12-14 | 2001-12-14 | |
| PCT/SE2002/001929 WO2003035061A1 (en) | 2001-10-23 | 2002-10-22 | Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005506368A JP2005506368A (ja) | 2005-03-03 |
| JP2005506368A5 true JP2005506368A5 (enExample) | 2006-01-05 |
Family
ID=26655574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537628A Pending JP2005506368A (ja) | 2001-10-23 | 2002-10-22 | 肥満の処置におけるまたは食物摂取の減少のためのインドールおよびインドリン誘導体の使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1438045B1 (enExample) |
| JP (1) | JP2005506368A (enExample) |
| AT (1) | ATE353646T1 (enExample) |
| CY (1) | CY1106566T1 (enExample) |
| DE (1) | DE60218194T2 (enExample) |
| DK (1) | DK1438045T3 (enExample) |
| ES (1) | ES2282495T3 (enExample) |
| PT (1) | PT1438045E (enExample) |
| WO (1) | WO2003035061A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2005005439A1 (en) * | 2003-07-09 | 2005-01-20 | Suven Life Sciences Limited | Benzothiazino indoles |
| HRP20060100T3 (en) | 2003-07-22 | 2007-03-31 | Arena Pharmaceuticals Inc | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| ES2222828B1 (es) | 2003-07-30 | 2006-04-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos. |
| GB0321473D0 (en) | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
| GB0322510D0 (en) | 2003-09-25 | 2003-10-29 | Glaxo Group Ltd | Novel compounds |
| CN1918173B (zh) | 2004-01-02 | 2011-09-14 | 苏文生命科学有限公司 | 新颖的茚并[2,1a]茚和异吲哚并[2,1-a]吲哚 |
| EP1734963A4 (en) | 2004-04-02 | 2008-06-18 | Merck & Co Inc | METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER |
| WO2008039087A2 (en) * | 2006-09-29 | 2008-04-03 | Auckland Uniservices Limited | Indoline derivatives and uses thereof |
| EP1947085A1 (en) * | 2007-01-19 | 2008-07-23 | Laboratorios del Dr. Esteve S.A. | Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| WO2009082268A2 (ru) | 2007-12-21 | 2009-07-02 | Alla Chem, Llc | ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN108676076A (zh) | 2011-03-01 | 2018-10-19 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| HK1220696A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 鸟苷酸环化酶激动剂及其用途 |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
| WO2017011767A2 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| KR20240046175A (ko) | 2021-07-07 | 2024-04-08 | 테란 바이오사이언시스 인코포레이티드 | N,n-디메틸트립타민 및 관련 사이키델릭스 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4576959A (en) * | 1984-02-06 | 1986-03-18 | Eli Lilly And Company | 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles |
| EP0375133A1 (en) * | 1988-11-14 | 1990-06-27 | The Upjohn Company | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| AU8876591A (en) * | 1990-11-02 | 1992-05-26 | Upjohn Company, The | Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
-
2002
- 2002-10-22 ES ES02786300T patent/ES2282495T3/es not_active Expired - Lifetime
- 2002-10-22 WO PCT/SE2002/001929 patent/WO2003035061A1/en not_active Ceased
- 2002-10-22 EP EP02786300A patent/EP1438045B1/en not_active Expired - Lifetime
- 2002-10-22 DE DE60218194T patent/DE60218194T2/de not_active Expired - Fee Related
- 2002-10-22 AT AT02786300T patent/ATE353646T1/de not_active IP Right Cessation
- 2002-10-22 PT PT02786300T patent/PT1438045E/pt unknown
- 2002-10-22 DK DK02786300T patent/DK1438045T3/da active
- 2002-10-22 JP JP2003537628A patent/JP2005506368A/ja active Pending
-
2007
- 2007-05-07 CY CY20071100610T patent/CY1106566T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005506368A5 (enExample) | ||
| ES2823825T3 (es) | Derivados de indol para su uso en medicina | |
| KR900018080A (ko) | 말레인이미드 유도체 및 약제로서 그의 용도 | |
| RU2003136731A (ru) | Новые производные индола со сродством к рецептору 5-нт6 | |
| US7297692B2 (en) | 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them | |
| BG107827A (bg) | Производни на 3-арилиндол и тяхното използване като св2 рецепторни антагонисти | |
| AU2813001A (en) | Use of glycogen phosphorylase inhibitors | |
| RU96111002A (ru) | 3-замещенные оксиндольные производные в качестве модуляторов калийных каналов, фармацевтическая композиция, способ лечения | |
| JP2004517072A (ja) | Ｃｎｓ障害の治療において有用な化合物 | |
| CN1294579A (zh) | 含有磺酰胺的吲哚化合物 | |
| JP2005506368A (ja) | 肥満の処置におけるまたは食物摂取の減少のためのインドールおよびインドリン誘導体の使用 | |
| CA2414938A1 (en) | Combinations of ssri and estrogenic agents | |
| CN110709385A (zh) | 赖氨酰氧化酶的卤代烯丙胺吡唑衍生物抑制剂及其用途 | |
| CN1379761A (zh) | 稠合二氢吲哚衍生物及其作为5ht特别是5ht2c受体配体的用途 | |
| WO2002003990A2 (en) | Use of substituted insole compounds for treating excessive intraocular pressure | |
| JP2006508131A5 (enExample) | ||
| CN85101761A (zh) | 新型色胺衍生物的制备方法和应用 | |
| HRP20040090A2 (en) | Arylsulfonyl derivatives with 5-ht<sub>6</sub> receptor affinity | |
| JP2009523729A (ja) | Ｃ型肝炎の治療方法 | |
| JP5368317B2 (ja) | 新規なインドール誘導体それらの製造方法および特に抗菌剤としてのそれらの使用 | |
| ZA200503231B (en) | 3-Phenyl substituted pyridoindolone, preparation and therapeutic use thereof | |
| KR20100074036A (ko) | 에티닐인돌 화합물 | |
| MX2008011015A (es) | Inhibidores de pai-1 para tratamiento de afecciones musculares. | |
| DK1406902T3 (da) | Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander | |
| CA2490115A1 (en) | Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |